Sincalide Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-579
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sincalide (NDC 63323-579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Kin0f 0001 02)
Principal Display Panel – Sincalide For Injection 5 Mcg Per Vial – Tray Label (Kin0f 0001 03)
This is a description of a medication with NDC code 63323-579-05, and it is available by prescription only. The medication comes in the form of a lyophilized powder, which needs to be reconstituted with sterile water for injection. The powder contains 5mg sincalide, 170mg mannitol, 70mg arginine hydrochloride, 15mg lysine hydrochloride, 9mg potassium phosphate dibasic, 4mg methionine, 2mg pentetic acid, 0.04mg sodium calcemate metabisulfite, and 0.005mcg polysorbate 20. The pH of the solution is adjusted to 6.0 - 8.0 with hydrochloric acid and/or sodium hydroxide. The medication comes in 10 single-dose vials and each vial contains 5mcg of sincalide. The medication is used for diagnostic purposes and the usual dose information can be found in the insert. It should be stored at 25°C (77°F) and after reconstitution, it can be stored at room temperature for up to 8 hours. The medication is manufactured by Fresenius Kabi.*
Principal Display Panel – Sincalide For Injection 5 Mcg Per Vial – Vial Label (Kin0f 0001 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.